Track the 프레스티지바이오로직스 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 프레스티지바이오로직스 has published 47 public disclosures. The latest transaction was reported on 10 July 2026 (Purchase). Among the most active insiders: 프레스티지바이오파마. Every trade is openly available.
47
Insider Decl.
n/a
Thresholds
n/a
39 ops.
Buy Volume
n/a
1 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Prestige Biologics is a company specializing in the manufacturing of biological products for the pharmaceutical industry. It is listed on the XKRX market.